Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

New hybrid procedures in treating occluded arteriovenous hemodialysis grafts

P. Bachleda, J. Janeckova, P. Xinopulos, O. Smakal

. 2016 ; 160 (1) : 149-152. [pub] 20160203

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17006135

Grantová podpora
NT14361 MZ0 CEP - Centrální evidence projektů

BACKROUND: The use of arteriovenous graft is indicated in patients if the subcutaneous venous bed is exhausted or unsuitable for arteriovenous fistula creation. The leading cause of failure of a prosthetic arteriovenous hemodialysis-access graft is venous anastomotic stenosis causing thrombosis of the graft. A number of surgical techniques and endovascular tools have been used to treat this stenosis and thrombosis. None have yet proven to be ideal. This study was designed to evaluate the results of hybrid treatment of arteriovenous graft thrombosis associated with venous anastomotic stenosis. METHODS: Over the period 2013-2014, we treated 16 AVG occlusions. Immediately after the diagnosis of occlusion was made, the patients underwent thrombectomy using a Fogarty catheter. After thrombectomy, a diagnostic fistulogram was performed and if VAG stenosis was confirmed, it was treated with balloon angioplasty and stent graft introduction. Lesions were dilated to reduce the stenosis in the treated area to less than 25%. RESULTS: Primary patency after 12 months was 32.8%. Primary assisted patency was 44.7%, secondary patency was 47.6%. Restenosis of the stent graft was seen in two patients. Recurring AVG occlusion was observed in four patients. The average number of interventions to maintain AVG patency was 1.18 per patient/1 year of dialysis. CONCLUSION: Treatment of AVG thrombosis due to VAG stenosis by hybrid procedure proved to be effective and improved secondary patency.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17006135
003      
CZ-PrNML
005      
20190104133526.0
007      
ta
008      
170210s2016 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2015.068 $2 doi
035    __
$a (PubMed)26847419
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bachleda, Petr, $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $d 1954- $7 jn20020716344
245    10
$a New hybrid procedures in treating occluded arteriovenous hemodialysis grafts / $c P. Bachleda, J. Janeckova, P. Xinopulos, O. Smakal
520    9_
$a BACKROUND: The use of arteriovenous graft is indicated in patients if the subcutaneous venous bed is exhausted or unsuitable for arteriovenous fistula creation. The leading cause of failure of a prosthetic arteriovenous hemodialysis-access graft is venous anastomotic stenosis causing thrombosis of the graft. A number of surgical techniques and endovascular tools have been used to treat this stenosis and thrombosis. None have yet proven to be ideal. This study was designed to evaluate the results of hybrid treatment of arteriovenous graft thrombosis associated with venous anastomotic stenosis. METHODS: Over the period 2013-2014, we treated 16 AVG occlusions. Immediately after the diagnosis of occlusion was made, the patients underwent thrombectomy using a Fogarty catheter. After thrombectomy, a diagnostic fistulogram was performed and if VAG stenosis was confirmed, it was treated with balloon angioplasty and stent graft introduction. Lesions were dilated to reduce the stenosis in the treated area to less than 25%. RESULTS: Primary patency after 12 months was 32.8%. Primary assisted patency was 44.7%, secondary patency was 47.6%. Restenosis of the stent graft was seen in two patients. Recurring AVG occlusion was observed in four patients. The average number of interventions to maintain AVG patency was 1.18 per patient/1 year of dialysis. CONCLUSION: Treatment of AVG thrombosis due to VAG stenosis by hybrid procedure proved to be effective and improved secondary patency.
650    _2
$a okluze cévního štěpu $x chirurgie $7 D006083
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční angiografie $7 D018810
650    12
$a dialýza ledvin $7 D006435
650    _2
$a stenty $7 D015607
650    _2
$a trombektomie $x metody $7 D017131
650    _2
$a trombóza $x chirurgie $7 D013927
650    _2
$a cévní přístupy $x škodlivé účinky $7 D062666
650    _2
$a průchodnost cév $7 D014654
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Janečková, Jana, $d 1982- $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $7 xx0227477
700    1_
$a Xinopulos, Pavel $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $7 xx0252532
700    1_
$a Šmakal, Oldřich $u Department of Urology, University Hospital Olomouc, Czech Republic $7 xx0140221
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 1 (2016), s. 149-152
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170210 $b ABA008
991    __
$a 20190104133721 $b ABA008
999    __
$a ok $b bmc $g 1192618 $s 966782
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 1 $d 149-152 $e 20160203 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NT14361 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20170210

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...